Stensvold, Stadskleiv, Myklebust, Wesenberg, Helseth, Bechensteen & Brandal (2020): Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors

I: Acta Pædiatrica, Online first, Open access

Forsidebilde fra tidsskriftet Acta Pædiatrica. Bilde av smilende baby


Einar Stensvold, Kristine Stadskleiv, Tor Åge Myklebust, Finn Wesenberg, Eirik Helseth, Anne Grete Bechensteen & Petter Brandal.


Aim: To study incidence, types and degrees of late effects in a geographical cohort of paediatric medulloblastoma and central nervous system primitive neuroectodermal tumour (CNS‐PNET) survivors, and identify the need for rehabilitation.

Methods: Between 1974 and 2013, 63 patients survived treatment for paediatric medulloblastoma and CNS‐PNET at Oslo University Hospital, Norway. Of these, 50 accepted invitation and were included in this study.

Results: Median follow‐up was 20 years (range 3.2‐41), and 96% of participants had developed late effects. Cognitive impairment was found in 72%, reduced hearing in 68%, endocrine deficits in 66%, epilepsy in 32% and another 30% had been diagnosed with one or more second primary neoplasms. Radiotherapy significantly increased risk of secondary primary neoplasms and endocrinological deficits, chemotherapy risk of ototoxicity and endocrinological deficits, and epilepsy was found significantly more often in CNS‐PNET than medulloblastoma patients. Epilepsy was the main cause of cognitive impairments (full‐scale IQ) in our study. 86% of participants had an unmet rehabilitation need.

Conclusion: Significant late effects and unmet rehabilitation needs were documented in the large majority of survivors after treatment for paediatric medulloblastoma and CNS‐PNET.

Publisert 7. feb. 2020 12:21 - Sist endret 7. feb. 2020 12:21